Allarity Therapeutics, Inc. Cash and Restricted Cash
Allarity Therapeutics, Inc. (ALLR) had Cash and Restricted Cash of $26.90 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $26.90M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $29.80M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $14.70M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.90M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $26.90M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $29.80M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $14.70M 10-K · filed 2026-03-30 |
| 2025-09-30 | $16.90M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $17.80M 10-Q · filed 2025-08-15 |
| 2025-03-31 | $27.70M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $19.50M 10-K · filed 2025-03-31 |
| 2024-09-30 | $18.50M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $19.23M 10-Q · filed 2024-08-05 |
| 2023-12-31 | $166.00K 10-Q · filed 2024-08-05 |
| 2023-06-30 | $420.00K 10-Q · filed 2024-08-05 |
| 2023-03-31 | $295.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.03M 10-Q · filed 2024-08-05 |
| 2022-09-30 | $3.95M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $7.68M 10-Q · filed 2022-10-07 |
| 2022-03-31 | $14.54M 10-Q · filed 2023-05-11 |
| 2021-12-31 | $19.55M 10-K · filed 2024-03-08 |
| 2021-09-30 | $5.58M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $6.60M 10-Q · filed 2022-10-07 |
| 2021-03-31 | $105.00K 10-Q · filed 2022-05-27 |
| 2020-12-31 | $298.00K 10-K · filed 2023-03-13 |
| 2020-09-30 | $30.00K 10-Q/A · filed 2022-05-17 |
| 2019-12-31 | $1.52M 10-Q/A · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |